NCT01566123View on ClinicalTrials.gov

Trial of Neoadjuvant Intensity-Modulated Radiation Therapy Followed by Surgery and Intraoperative Radiation Therapy in Resectable Retroperitoneal Soft Tissue Sarcoma (RETRO-WTS)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

January 31, 2020

Study Completion Date

February 29, 2020

Conditions
Retroperitoneal Soft Tissue Sarcoma
Interventions
RADIATION

Neoadjuvant intensity-modulated radiation therapy (IMRT)

neoadjuvant intensity-modulated radiation therapy, single dose 2.0-2.4 Gy, total dose 50-56 Gy

RADIATION

intraoperative radiation therapy (IORT)

during surgery, 10-12 Gy (90% isodose) to the tumor bed or residual disease

Trial Locations (1)

69120

University Hospital Heidelberg, Heidelberg

All Listed Sponsors
collaborator

German Cancer Research Center

OTHER

lead

University Hospital Heidelberg

OTHER

NCT01566123 - Trial of Neoadjuvant Intensity-Modulated Radiation Therapy Followed by Surgery and Intraoperative Radiation Therapy in Resectable Retroperitoneal Soft Tissue Sarcoma (RETRO-WTS) | Biotech Hunter | Biotech Hunter